The National Institutes of Health (NIH) yesterday announced that researchers have started enrolling participants in a phase 1 clinical trial to evaluate immunogenicity and safety of two licensed seasonal flu vaccines given with and without novel adjuvants.
Emergent BioSolutions announced yesterday that the US Health and Human Services (HHS) Biomedical Advanced Research and Development Authority (BARDA) has exercised a contract option worth $261 million to buy doses of anthrax vaccine adsorbed with adjuvant (AV7909) for the Strategic National Stockpile (SNS).
An effort to reduce inappropriate antibiotic prescribing in New York City hospitals was associated with a modest decrease in prescribing for acute respiratory infections (ARIs), according to a study today in Infection Control and Hospital Epidemiology.
Treatment with neuraminidase inhibitors when patients are first admitted for flu reduced the length of hospitalization by 19%, according to a meta-analysis published yesterday in the Journal of Infectious Diseases.
The World Health Organization (WHO) European regional office said yesterday that the region achieved 91% coverage for the second dose of measles vaccine, signifying the second consecutive year that the area has reached a record high.
The efficacy of malaria vaccine RTS,S/AS01 in infants and children is sustained for up to 7 years after vaccination, according to an extension study published Jul 9 in The Lancet Infectious Diseases following a previous phase 3 study.
President Trump yesterday signed bipartisan legislation reauthorizing the Pandemic and All-Hazards Preparedness and Advancing Innovations Act (PAHPA), which plays a crucial role in preparing the country for natural or manmade biological threats such as pandemic flu or a bioterror attack.
"The fact that Congress passed this bill is acknowledgement that health security is national security."
A multistate Escherichia coli O103 outbreak from a still-unidentified source has sickened 24 more people, with 96 cases reported so far, the Centers for Disease Control and Prevention (CDC) said yesterday. The number of affected states remained at five: Kentucky (46 cases), Tennessee (26), Georgia (17), Ohio (5), and Virginia (2).
The University of Minnesota's Center for Infectious Disease Research and Policy (CIDRAP) today announced the launch of the Chronic Wasting Disease Response, Research, and Policy Program (CWD Program) to address the wildlife disease crisis and the potential for zoonotic spread and human-to-human transmission. CIDRAP is the publisher of CIDRAP News.
